SL Science Holding Limited Company Profile
NASDAQ: SLBTHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
SL Science at a glance
SL Science Holding Limited (NASDAQ: SLBT) is a Biotechnology: Biological Products (No Diagnostic Substances) company in the Health Care sector headquartered in Taipei, Taiwan. SL Science is led by Mr. Ching-Dong Wang and employs about 14 people. At a market capitalization of $846.7 million, it is considered a small-cap company.
Its SEC Central Index Key (CIK) is 0002070534, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does SL Science do?
SL Science Holding Limited manufactures cosmetic skin care and scalp care products. The company's products include SL bio's milk-derived exosome essence, SL bio's tangerine-derived extract, and the MilkExo concentrate series. It also offers research services in armed T-cells, gamma delta T- cells, citrus reticulata (tangerine) extract, and milk-derived exosomes. SL Science Holding Limited was formerly known as SL BIO Co., Ltd. and changed its name to SL Science Holding Limited in June 2026. The company is based in Taipei, Taiwan.
Business description based on the company's public filings.
Company information
- Legal name
- SL Science Holding Limited
- Ticker
- NASDAQ: SLBT
- Sector
- Health Care
- Industry
- Biotechnology: Biological Products (No Diagnostic Substances)
- CEO
- Mr. Ching-Dong Wang
- Employees
- 14
- Headquarters
- No. 479, Chongyang Rd., Taipei, Taiwan
- Phone
- 886 2 2651 6826
- Website
- sl-bio.com
- Market cap
- $846.75M
- SEC CIK
- 0002070534
Companies similar to SL Science
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| SANASana Biotechnology Inc. | 2.79 | +2.57% | $835.22M | vs SLBT |
| ODTXOdyssey Therapeutics Inc. | 18.12 | +0.22% | $870.82M | vs SLBT |
| GLUEMonte Rosa Therapeutics Inc. | 10.32 | +1.47% | $880.43M | vs SLBT |
| CGEMCullinan Therapeutics Inc. | 15.46 | -1.09% | $950.14M | vs SLBT |
| SLDBSolid Biosciences Inc. | 6.82 | -0.44% | $731.28M | vs SLBT |
| FDMT4D Molecular Therapeutics Inc. | 12.70 | +0.87% | $701.60M | vs SLBT |
| AURAAura Biosciences Inc. | 6.51 | +0.70% | $674.60M | vs SLBT |
| PROKProKidney Corp. Class A | 1.66 | +5.73% | $662.64M | vs SLBT |